NASDAQ: AGRX
Agile Therapeutics Inc Stock Ownership

Insider buying vs selling

Have Agile Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Advisors Llc Perceptive10% Owner2021-10-135,734,560$0.85
$4.87MBuy
Alfred AltomariChief Executive Officer2021-07-2926,200$1.26
$33.09kBuy
Dennis ReillyChief Financial Officer2021-07-2750,000$1.08
$54.15kBuy
Alfred AltomariChief Executive Officer2021-05-1820,000$1.61
$32.20kBuy
Dennis ReillyChief Financial Officer2021-05-1120,000$1.35
$27.00kBuy
Jason ButchPrincipal Accounting Officer2021-03-291,358$1.99
$2.70kBuy
Jason ButchPrincipal Accounting Officer2021-03-268,642$2.01
$17.37kBuy
Dennis ReillyChief Financial Officer2021-03-2350,000$2.05
$102.50kBuy
Alfred AltomariChief Executive Officer2021-03-2312,500$2.00
$25.02kBuy

1 of 1

AGRX insiders have bought more... subscribe to Premium to read more.
Ownership

AGRX Shareholders

What type of owners hold Agile Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Advisors Llc Perceptive17.84%21,654,485$6.50MInsider
Perceptive Advisors LLC13.11%15,919,925$4.78MInstitution
Capital Iii Llc Care4.55%5,520,378$1.66MInsider
Jay Moorin4.17%5,065,086$1.52MInsider
Capital Iii Lp Aisling3.92%4,755,628$1.43MInsider
Vanguard Group Inc3.38%4,104,848$1.23MInstitution
Investor Ab2.89%3,510,189$1.05MInstitution
Ab Investor2.89%3,509,949$1.05MInsider
Andrew N. Schiff1.79%2,171,831$651.55kInsider
Blackrock Inc1.21%1,470,260$441.08kInstitution

1 of 3

Agile Therapeutics Stock Ownership FAQ

Who owns Agile Therapeutics?

Agile Therapeutics (NASDAQ: AGRX) is owned by 26.18% institutional shareholders, 36.54% Agile Therapeutics insiders, and 37.28% retail investors. Advisors Llc Perceptive is the largest individual Agile Therapeutics shareholder, owning 21.65M shares representing 17.84% of the company. Advisors Llc Perceptive's Agile Therapeutics shares are currently valued at $6.95M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.